• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过研究基因修饰对构象的影响来开发双功能重组人重链铁蛋白的纯化工艺。

Development of purification process for dual-function recombinant human heavy-chain ferritin by the investigation of genetic modification impact on conformation.

作者信息

Yin Shuang, Zhang Bingyang, Lin Jianying, Liu Yongdong, Su Zhiguo, Bi Jingxiu

机构信息

School of Chemical Engineering & Advanced Materials Faculty of Engineering, Computer and Mathematical Sciences University of Adelaide Adelaide Australia.

College of Biomedical Engineering Taiyuan University of Technology Taiyuan P. R. China.

出版信息

Eng Life Sci. 2021 Jun 19;21(10):630-642. doi: 10.1002/elsc.202000105. eCollection 2021 Oct.

DOI:10.1002/elsc.202000105
PMID:34690634
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8518560/
Abstract

Ferritin is a promising drug delivery platform and has been functionalized through genetic modifications. This work has designed and expressed a dual-functional engineered human heavy-chain ferritin (HFn) with the inserted functional peptide PAS and RGDK to extend half-life and improve tumor targeted drug delivery. A facile and cost-effective two-step purification pathway for recombinant HFn was developed. The genetic modification was found to affect HFn conformation, and therefore varied the purification performance. Heat-acid precipitation followed by butyl fast flow hydrophobic interaction chromatography (HIC) has been developed to purify HFn and modified HFns. Nucleic acid removal reached above 99.8% for HFn and modified HFns. However, HFn purity reached above 95% and recovery yield (overall) above 90%, compared with modified HFns purity above 82% and recovery yield (overall) above 58%. It is interesting to find that the inserted functional peptides significantly changed the molecule conformation, where a putative turnover of the E-helix with the inserted functional peptides formed a "flop" conformation, in contrast with the "flip" conformation of HFn. It could be the cause of fragile stability of modified HFns, and therefore less tolerant to heat and acid condition, observed by the lower recovery yield in heat-acid precipitation.

摘要

铁蛋白是一种很有前景的药物递送平台,并且已通过基因改造实现了功能化。这项工作设计并表达了一种具有插入功能肽PAS和RGDK的双功能工程化人重链铁蛋白(HFn),以延长半衰期并改善肿瘤靶向药物递送。开发了一种简便且经济高效的重组HFn两步纯化途径。发现基因改造会影响HFn的构象,因此改变了纯化性能。已开发出先进行热酸沉淀,然后进行丁基快速流动疏水相互作用色谱(HIC)的方法来纯化HFn和修饰后的HFn。HFn和修饰后的HFn的核酸去除率达到99.8%以上。然而,HFn的纯度达到95%以上,总回收率达到90%以上,相比之下,修饰后的HFn纯度在82%以上,总回收率在58%以上。有趣的是,发现插入的功能肽显著改变了分子构象,其中插入功能肽后E螺旋的推定翻转形成了“耷拉”构象,这与HFn的“翻转”构象形成对比。这可能是修饰后的HFn稳定性脆弱的原因,因此在热酸沉淀中观察到其对热和酸条件的耐受性较低,回收率也较低。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2641/8518560/6e8b25dd2854/ELSC-21-630-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2641/8518560/60185db8f125/ELSC-21-630-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2641/8518560/0e0e98458903/ELSC-21-630-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2641/8518560/7f52abd07034/ELSC-21-630-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2641/8518560/2715f6663e0b/ELSC-21-630-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2641/8518560/0f14742449ae/ELSC-21-630-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2641/8518560/76a8ef044fd1/ELSC-21-630-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2641/8518560/6e8b25dd2854/ELSC-21-630-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2641/8518560/60185db8f125/ELSC-21-630-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2641/8518560/0e0e98458903/ELSC-21-630-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2641/8518560/7f52abd07034/ELSC-21-630-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2641/8518560/2715f6663e0b/ELSC-21-630-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2641/8518560/0f14742449ae/ELSC-21-630-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2641/8518560/76a8ef044fd1/ELSC-21-630-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2641/8518560/6e8b25dd2854/ELSC-21-630-g007.jpg

相似文献

1
Development of purification process for dual-function recombinant human heavy-chain ferritin by the investigation of genetic modification impact on conformation.通过研究基因修饰对构象的影响来开发双功能重组人重链铁蛋白的纯化工艺。
Eng Life Sci. 2021 Jun 19;21(10):630-642. doi: 10.1002/elsc.202000105. eCollection 2021 Oct.
2
Engineered Human Heavy-Chain Ferritin with Half-Life Extension and Tumor Targeting by PAS and RGDK Peptide Functionalization.通过PAS和RGDK肽功能化延长半衰期并实现肿瘤靶向的工程化人重链铁蛋白
Pharmaceutics. 2021 Apr 9;13(4):521. doi: 10.3390/pharmaceutics13040521.
3
Mechanism Study of Thermally Induced Anti-Tumor Drug Loading to Engineered Human Heavy-Chain Ferritin Nanocages Aided by Computational Analysis.基于计算分析的热诱导载抗肿瘤药物进入工程化人重链铁蛋白纳米笼的机制研究。
Biosensors (Basel). 2021 Nov 11;11(11):444. doi: 10.3390/bios11110444.
4
Ferritin: A Multifunctional Nanoplatform for Biological Detection, Imaging Diagnosis, and Drug Delivery.铁蛋白:用于生物检测、成像诊断和药物输送的多功能纳米平台。
Acc Chem Res. 2021 Sep 7;54(17):3313-3325. doi: 10.1021/acs.accounts.1c00267. Epub 2021 Aug 20.
5
Extending Half Life of H-Ferritin Nanoparticle by Fusing Albumin Binding Domain for Doxorubicin Encapsulation.通过融合白蛋白结合结构域延长 H 型铁蛋白纳米颗粒的半衰期以包载阿霉素。
Biomacromolecules. 2018 Mar 12;19(3):773-781. doi: 10.1021/acs.biomac.7b01545. Epub 2018 Feb 5.
6
Heat sensitive E-helix cut ferritin nanocages for facile and high-efficiency loading of doxorubicin.热敏感 E 螺旋切割 ferrtin 纳米笼,用于阿霉素的简便高效装载。
Int J Biol Macromol. 2023 Dec 31;253(Pt 3):126973. doi: 10.1016/j.ijbiomac.2023.126973. Epub 2023 Sep 18.
7
Rational design of engineered H-ferritin nanoparticles with improved siRNA delivery efficacy across an model of the mouse BBB.通过工程化 H 铁蛋白纳米颗粒的合理设计,提高了 siRNA 在小鼠 BBB 模型中的递送效果。
Nanoscale. 2022 May 5;14(17):6449-6464. doi: 10.1039/d1nr07880a.
8
Cargo loading within ferritin nanocages in preparation for tumor-targeted delivery.为肿瘤靶向递药而在铁蛋白纳米笼内进行货物装载。
Nat Protoc. 2021 Oct;16(10):4878-4896. doi: 10.1038/s41596-021-00602-5. Epub 2021 Sep 8.
9
Ferritin nanocages for early theranostics of tumors via inflammation-enhanced active targeting.基于炎症增强的主动靶向的铁蛋白纳米笼用于肿瘤的早期治疗学。
Sci China Life Sci. 2022 Feb;65(2):328-340. doi: 10.1007/s11427-021-1976-0. Epub 2021 Aug 31.
10
Target delivering paclitaxel by ferritin heavy chain nanocages for glioma treatment.载紫杉醇的铁蛋白重链纳米笼用于治疗脑胶质瘤。
J Control Release. 2020 Jul 10;323:191-202. doi: 10.1016/j.jconrel.2019.12.010. Epub 2019 Dec 12.

引用本文的文献

1
Re-engineering the inner surface of ferritin nanocage enables dual drug payloads for synergistic tumor therapy.对铁蛋白纳米笼的内表面进行再工程化处理,实现了双重药物载荷,用于协同肿瘤治疗。
Theranostics. 2022 Jan 24;12(4):1800-1815. doi: 10.7150/thno.68459. eCollection 2022.
2
Mechanism Study of Thermally Induced Anti-Tumor Drug Loading to Engineered Human Heavy-Chain Ferritin Nanocages Aided by Computational Analysis.基于计算分析的热诱导载抗肿瘤药物进入工程化人重链铁蛋白纳米笼的机制研究。
Biosensors (Basel). 2021 Nov 11;11(11):444. doi: 10.3390/bios11110444.

本文引用的文献

1
Virus-like particle preparation is improved by control over capsomere-DNA interactions during chromatographic purification.通过控制色谱纯化过程中衣壳-DNA 相互作用,可提高病毒样颗粒制剂的质量。
Biotechnol Bioeng. 2021 Apr;118(4):1707-1720. doi: 10.1002/bit.27687. Epub 2021 Feb 19.
2
Albumin-neprilysin fusion protein: understanding stability using small angle X-ray scattering and molecular dynamic simulations.白蛋白-脑啡肽酶融合蛋白:使用小角度 X 射线散射和分子动力学模拟来理解稳定性。
Sci Rep. 2020 Jun 22;10(1):10089. doi: 10.1038/s41598-020-67002-9.
3
Ferritin-Displayed GLP-1 with Improved Pharmacological Activities and Pharmacokinetics.
具有改善的药代动力学和药理学活性的铁蛋白展示 GLP-1。
Mol Pharm. 2020 May 4;17(5):1663-1673. doi: 10.1021/acs.molpharmaceut.0c00098. Epub 2020 Apr 13.
4
Targeted cancer cell delivery of arsenate as a reductively activated prodrug.砷酸盐作为还原激活前药的靶向癌细胞递送。
J Biol Inorg Chem. 2020 May;25(3):441-449. doi: 10.1007/s00775-020-01774-3. Epub 2020 Mar 18.
5
TfR1 binding with H-ferritin nanocarrier achieves prognostic diagnosis and enhances the therapeutic efficacy in clinical gastric cancer.TfR1 与 H 铁蛋白纳米载体结合可实现临床胃癌的预后诊断和增强治疗效果。
Cell Death Dis. 2020 Feb 5;11(2):92. doi: 10.1038/s41419-020-2272-z.
6
Protein A chromatography: Challenges and progress in the purification of monoclonal antibodies.蛋白 A 层析法:单克隆抗体纯化中的挑战与进展。
J Sep Sci. 2019 May;42(9):1816-1827. doi: 10.1002/jssc.201800963. Epub 2019 Mar 21.
7
Ferritin nanocage with intrinsically disordered proteins and affibody: A platform for tumor targeting with extended pharmacokinetics.载有内在无序蛋白和亲和体的铁蛋白纳米笼:用于具有延长药代动力学的肿瘤靶向的平台。
J Control Release. 2017 Dec 10;267:172-180. doi: 10.1016/j.jconrel.2017.08.014. Epub 2017 Aug 15.
8
Cisplatin Binding Sites in Human H-Chain Ferritin.顺铂在人H链铁蛋白中的结合位点。
Inorg Chem. 2017 Aug 7;56(15):9064-9070. doi: 10.1021/acs.inorgchem.7b01072. Epub 2017 Jul 24.
9
"Silent" Amino Acid Residues at Key Subunit Interfaces Regulate the Geometry of Protein Nanocages.“沉默”的氨基酸残基位于关键亚基界面调节蛋白纳米笼的几何形状。
ACS Nano. 2016 Nov 22;10(11):10382-10388. doi: 10.1021/acsnano.6b06235. Epub 2016 Nov 9.
10
Half-Life Extension of Biopharmaceuticals using Chemical Methods: Alternatives to PEGylation.使用化学方法延长生物制药的半衰期:聚乙二醇化的替代方法
ChemMedChem. 2016 Nov 21;11(22):2474-2495. doi: 10.1002/cmdc.201600374. Epub 2016 Oct 24.